Collecting data on COPD exacerbations in hospitalized patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The CATALINA study is a prospective cohort study aimed at gathering standardized clinical data and biological samples from 1000 patients hospitalized for acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD). Conducted across 20 centers in Europe, the study involves multiple scheduled visits during hospitalization and outpatient follow-ups over a year. The goal is to create a comprehensive biobank and patient data repository to support future clinical trials and prognostic tools for COPD exacerbations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 years and older
* Established diagnosis of COPD by medical doctor (based on clinical history OR pulmonary function test with an FEV1/FVC \< 0.7)
* Current hospitalization with suspicion of an acute exacerbation of COPD (AECOPD)
* Inclusion within 48 hours post hospital admission
* Voluntary written informed consent of the participant or his/her representative obtained prior to any study procedure

Exclusion Criteria:

* Patients unwilling or unable to comply with study procedures
* Patients not requiring treatment with systemic corticosteroids, antibiotics or both as a minimum therapy for the index AECOPD
* Patients with a confirmed positive test result for COVID19, or those highly suspected based on clinical examination

Where it's running

• Kepler University Hospital
  Linz, Austria Recruiting
• CHU St-Pierre Brussels
  Brussels, Belgium Recruiting
• UZ Leuven
  Leuven, Belgium Recruiting
• CHU UCL Namur Site Godinne
  Yvoir, Belgium Recruiting
• LungenClinic
  Großhansdorf, Germany Recruiting
• Klinikum Itzehoe
  Itzehoe, Germany Recruiting

Study contacts

• Study coordinator: Kristina Vermeersch, PhD
• Email: kristina.vermeersch@kuleuven.be
• Phone: 016342284

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Neutrophil-to-lymphocyte ratio in COPD flare-ups.

  This project will test whether a routine blood measure called the neutrophil-to-lymphocyte ratio can help predict severity, outcomes, and treatment response in adults hospitalized with COPD flare-ups.

  Recruiting Ain Shams University · Cairo, Abbasyea · NCT07125352

• Non-invasive ventilation or CPAP for COPD with sleep apnea after a serious COPD flare

  This study tests whether non-invasive ventilation (NIV) or CPAP can help adults with COPD and coexisting obstructive sleep apnea after a severe COPD flare requiring hospital care.

  Recruiting Phase 3 Assistance Publique - Hôpitaux de Paris · Paris · NCT07047092

• Cycling with immersive VR for ICU patients recovering from critical illness

  In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.

  Recruiting KU Leuven · Leuven · NCT07894146

• Personalised nutrition tool for teens undergoing cancer treatment

  A smartphone app called MybYte tests a tailored nutrition plan for teenagers aged 12–18 who are receiving cancer treatment to see if it is helpful and easy to use.

  Recruiting KU Leuven · Leuven, Vlaams Brabant · NCT07865117

• UCB8600 and mast cell activation in the gut for IBS

  This study tests whether UCB8600 can reduce mast cell activation in the gut to help people with IBS.

  Recruiting KU Leuven · Leuven, Vlaams-Brabant · NCT07655375

• Foot position during Achilles tendinopathy rehab

  This trial tests whether doing a 12-week load-based exercise with a toes-out foot position helps the Achilles better heal and function compared with a neutral foot position in adults with mid-portion Achilles tendinopathy.

  Recruiting KU Leuven · Leuven, Vlaams-Brabant · NCT07623408

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.